Hypereosinophilic syndrome with central nervous system involvement treated with anti-IL-5 therapy

Publication date: June 2021Source: Multiple Sclerosis and Related Disorders, Volume 51Author(s): M. Jonakowski, I. Kuprys-Lipinska, P. Lacwik, M. Stasiolek, M. Matysiak

Source: Multiple Sclerosis and Related Disorders - March 9, 2021 Category: Neurology Source Type: research